Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byoung Chul Cho

Showing results (31-40 of 453) with videos related to

Pageof 46
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 5, 2025
A Response to the Letter to the Editor: "Durable Benefit Beyond Response: Reinterpreting Amivantamab Efficacy in METex14 NSCLC Subgroups"Matthew G Krebs, Byoung Chul Cho, Priya Kim, et al.
JTO Clinical and Research Reports|September 30, 2021
Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and SavolitinibSun Min Lim, San-Duk Yang, Sangbin Lim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2018
Can We Prevent Resistance to Osimertinib? Combination or SequentialMin Hwan Kim, Sun Min Lim, Kwangho Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
Clinical course of stage IV invasive mucinous adenocarcinoma of the lungYoon Jin Cha, Hye Ryun Kim, Hye-Jeong Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 statusYoon Jin Cha, Hye Ryun Kim, Chang Young Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 12, 2016
A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to CrizotinibYoon Jin Cha, Byoung Chul Cho, Hye Ryun Kim, et al.
Anticancer Research|November 10, 2019
Twist and Snail/Slug Expression in Oropharyngeal Squamous Cell Carcinoma in Correlation With Lymph Node MetastasisYoon Ah Cho, Eun Kyung Kim, Byoung Chul Cho, et al.
Therapeutic Advances in Medical Oncology|February 9, 2023
Advances in the management of non-small-cell lung cancer harbouring <i>EGFR</i> exon 20 insertion mutationsJia Li Low, Sun Min Lim, Jii Bum Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIsJi Soo Park, Min Hee Hong, You Jin Chun, et al.
Yonsei Medical Journal|December 27, 2007
A case of successful intrapleural chemotherapy with Cisplatin plus cytarabine for intractable malignant pleural effusionYong Wha Moon, Sang Tae Choi, Byoung Chul Cho, et al.
Pageof 46

Showing results (31-40 of 453) with videos related to

Sort By:
Pageof 46
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 5, 2025
A Response to the Letter to the Editor: "Durable Benefit Beyond Response: Reinterpreting Amivantamab Efficacy in METex14 NSCLC Subgroups"Matthew G Krebs, Byoung Chul Cho, Priya Kim, et al.
JTO Clinical and Research Reports|September 30, 2021
Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and SavolitinibSun Min Lim, San-Duk Yang, Sangbin Lim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2018
Can We Prevent Resistance to Osimertinib? Combination or SequentialMin Hwan Kim, Sun Min Lim, Kwangho Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
Clinical course of stage IV invasive mucinous adenocarcinoma of the lungYoon Jin Cha, Hye Ryun Kim, Hye-Jeong Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 statusYoon Jin Cha, Hye Ryun Kim, Chang Young Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 12, 2016
A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to CrizotinibYoon Jin Cha, Byoung Chul Cho, Hye Ryun Kim, et al.
Anticancer Research|November 10, 2019
Twist and Snail/Slug Expression in Oropharyngeal Squamous Cell Carcinoma in Correlation With Lymph Node MetastasisYoon Ah Cho, Eun Kyung Kim, Byoung Chul Cho, et al.
Therapeutic Advances in Medical Oncology|February 9, 2023
Advances in the management of non-small-cell lung cancer harbouring <i>EGFR</i> exon 20 insertion mutationsJia Li Low, Sun Min Lim, Jii Bum Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIsJi Soo Park, Min Hee Hong, You Jin Chun, et al.
Yonsei Medical Journal|December 27, 2007
A case of successful intrapleural chemotherapy with Cisplatin plus cytarabine for intractable malignant pleural effusionYong Wha Moon, Sang Tae Choi, Byoung Chul Cho, et al.
Pageof 46